Agape ATP Corp
ATPCConsumer Defensive·Packaged Foods·Malaysia·Nano·NASD·Nov 12 • 3:45 PM ET
Price
ATPC against its 20, 50 and 200-day averages98.1% under the 52-week high of 73.50 on 9 Dec 2025. 52-week low 1.15 on 3 Nov 2026. Last 15 sessions, 50.4% high to low
Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average
Setup. RS line 0
CANSLIM 1 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%; Average Volume: Over 200K — not on the tape: EPS Growth This Year: High (>25%)
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 1 of 4 — fails: Return on Equity: Over +15% — not on the tape: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%)
Quality 2 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%) — not on the tape: P/E: Under 25
Value 2 of 4 — fails: Return on Equity: Over +15% — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 1 of 4 — fails: Institutional Ownership: Over 30%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K
Profile
ATPCAgape ATP Corp. engages in the provision of health and wellness products and advisory services in the Malaysian market. It offers four series of products: ATP Zeta Health Program, ENERGETIQUE, E.A.T.S. and BEAUNIQUE. The company was founded by How Kok Choong on June 1, 2016 and is headquartered in Kuala Lumpur, Malaysia.
| Employees | 18 |
|---|---|
| IPO | Oct 11, 2023 |
| Beta | 0.96 |
| ATR, 14d | 0.18 |
| Rel volume | 0.00 |
| Short float | 0.41% |
| Insider own | 52.57% |
| Inst own | 10.03% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | $1.36M |
| Enterprise Value | -23.16M |
| Income | -1.21M |
| Sales | 1.06M |
| Book / share | 22.04 |
| Cash / share | 24.58 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 18 |
| IPO | Oct 11, 2023 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 1.28 |
| Price / book | 0.06 |
| Price / cash | 0.06 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | -21.85 |
| Quick Ratio | 8.37 |
| Current Ratio | 8.45 |
| Debt / equity | 0.00 |
| Long-term debt / equity | 0.00 |
| Options and short | No / Yes |
Earnings
| Earnings / share | -1.21 |
|---|---|
| Earnings next year | - |
| Earnings next quarter | - |
| Earnings this year | - |
| Earnings next year | - |
| Earnings growth, 5 years | - |
| Past earnings growth | 47.09% - |
| Past sales growth | -6.36% -15.09% |
| Earnings vs last year | 94.21% |
| Sales vs last year | -26.88% |
| Earnings vs last quarter | 112.67% |
| Sales vs last quarter | -97.06% |
| Earnings | - |
| Surprise | - - |
Ownership
| Insiders own | 52.57% |
|---|---|
| Insider trades | 0.00% |
| Institutions own | 10.03% |
| Institution trades | 54.34% |
| Return on assets | -4.84% |
| Return on equity | -5.30% |
| Return on capital | -5.49% |
| Gross Margin | 56.99% |
| Operating margin | -295.88% |
| Profit Margin | -114.76% |
| 20-day average | -4.80% |
| 50-day average | -27.69% |
| 200-day average | -46.06% |
Technical
| Shares out | 1.00M |
|---|---|
| Shares floating | 0.47M |
| Short / float | 0.41% |
| Short ratio | 0.06 |
| Short interest | 0.00M |
| 52-week high | 73.50 -98.1% |
| 52-week low | 1.15 +18.3% |
| Volatility | 9.50% 12.07% |
| Average range | 0.18 |
| Strength index | 39.10 |
| Market sensitivity | 0.96 |
| Relative volume | 0.00 |
| Avg Volume | 34.60K |
| Volume | 0 |
Performance
| Perf Week | 5.43% |
|---|---|
| Perf Month | -22.73% |
| Perf Quarter | -45.38% |
| Perf Half Y | -37.61% |
| Perf YTD | -74.46% |
| Perf Year | -98.03% |
| Perf 3Y | -99.87% |
| Perf 5Y | -99.98% |
| Perf 10Y | - |
| Recommendation | - |
| Target Price | - |
| Prev Close | 1.36 |
| Price | 1.36 |
| Change % | 0.00% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| USNA | Usana Health Sciences Inc | 235.21M |
| NATR | Nature's Sunshine Products Inc | 178.14M |
| HLF | Herbalife Ltd | 1.60B |
| LFVN | Lifevantage Corp | 63.92M |
| NAII | Natural Alternatives International Inc | 5.96M |
| PRE | Prenetics Global Limited | 283.20M |
| FTLF | FitLife Brands Inc | 77.95M |
| MTEX | Mannatech Inc | 17.33M |
| NUS | Nu Skin Enterprises Inc | 195.20M |
| NHTC | Natural Health Trends Corp | 7.47M |
News
latest 14 of 54- Agape ATP Corporation Regains Compliance with Nasdaq Minimum Bid Price Requirement (ACCESSWIRE) +35.49%
- AGAPE ATP Corporation Forges Strategic Collaboration with UAE-Based Citadel Investment (ACCESSWIRE) +87.13%
- Agape ATP Corporation Announces 1-For-50 Reverse Stock Split (ACCESSWIRE) -22.22%
- Agape ATP Corporation Receives Nasdaq Delisting Notice (ACCESSWIRE) -25.00%
- Agape ATP Corporation Receives Nasdaq Notice on Minimum Bid Price Requirement (ACCESSWIRE)
- Agape ATP (ATPC) Stock Surged 65% After-Hours: What's Happening? (Benzinga) +56.00%
- Agape ATP Corporation Issues Statement on Recent Market Activity and Reaffirms Strategic Outlook (ACCESSWIRE) -25.07%
- Agape ATP Corporation Signs Strategic Partnerships Agreement to Advance Global Energy and Infrastructure Initiatives (ACCESSWIRE)
- Why Agape ATP Corporation (ATPC) is Surging in 2025 (Insider Monkey)
- Agape ATP Corporation Announces Key USD23.0 Million Private Placement to Institutional Investors (ACCESS Newswire)
- Agape ATP Corporation Signs ICPO with Swiss One Oil & Gas AG for 200,000 MT of EN590 and 2,000,000 Barrels of Jet Fuel A1 (ACCESSWIRE) +70.94%
- ATPC Expands Global Market Footprint to Spearhead Medical Innovation with MoUs in Indonesia (ACCESSWIRE)
- Agape ATP Corporation - Synergising Innovation Across Business Pillars to Make the World a Better Place (ACCESSWIRE) -5.14%
- ATPC and FORMEDIC Technologies Announce Strategic Collaboration to Launch LEGA, a Revolutionary Respiratory Care Device (ACCESSWIRE)
Quarterly earnings
actual against estimate
No quarterly earnings.
Annual earnings
No annual earnings.
Quarterly results
2026Q2 revenue 0.01, from 0.47 a year earlier. Operating margin -5,500%, from -136.17% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type.
No estimate revisions.
Estimate history
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.35 | -1.8 | 0.94 | -6.71 | -19.21 | -27.73 | -31.738 | -2.846 | -1.2127 | - |
| Sales USD millions | 0 | 1 | 3 | 1 | 2 | 1 | 1 | 2 | 1 | - |
| Shares million shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | - | 1 |
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -5.75 | -6.566 | -10.133 | -3.633 | -0.617 | -0.587 | -0.377 | -0.327 | 0.078 |
| Sales USD millions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares million shares | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2019FY6/30/2019 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.06 | 1.52+15.2% | 1.32-7.7% | 1.43-23.1% | 1.86+82.4% | 1.02-70.4% | 3.45+301.2% | 0.86 | 1.55 |
| Cost of Goods Sold Incl. D&A | 0.45 | 0.71+14.5% | 0.62+10.7% | 0.56-24.3% | 0.74+100.0% | 0.37-52.6% | 0.78+1.3% | 0.77 | 1.44 |
| Gross Profit | 0.60 | 0.82+15.5% | 0.71-18.4% | 0.87-22.3% | 1.12+75.0% | 0.64-76.1% | 2.68+2877.8% | 0.09 | 0.11 |
| Selling, General and Administrative Excl. Other | 3.73 | 4.07+24.1% | 3.28+9.0% | 3.01+13.6% | 2.65+6.0% | 2.50-11.7% | 2.83+356.5% | 0.62 | 0.61 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -3.13 | -3.26 | -2.57 | -2.15 | -1.53 | -1.86 | -0.16 | -0.53 | -0.50 |
| Interest Expense | - | - | - | - | 0.00 | 0.00 | 0.00 | - | - |
| Unusual Expense | 0.00 | -0.01-200.0% | 0.01 | -0.00-100.0% | 0.07-86.3% | 0.51 | -0.35-350.0% | 0.14 | - |
| Net Income Before Taxes | -1.23 | -2.31 | -2.48 | -2.11 | -1.67 | -2.39-559.6% | 0.52 | -0.68 | -0.52 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | -0.00-100.0% | 0.14-12.5% | 0.16 | 0.00 | 0.00 |
| Consolidated Net Income | -1.23 | -2.31 | -2.49 | -2.11 | -1.67 | -2.52-820.0% | 0.35 | -0.68 | -0.52 |
| Net Income From Continuing Operations | -1.20 | -2.28 | -2.47 | -2.10 | -1.69 | -2.52-820.0% | 0.35 | -0.68 | -0.52 |
| Net Income | -1.21 | -2.28 | -2.47 | -2.10 | -1.69 | -2.52-820.0% | 0.35 | -0.68 | -0.52 |
| EPS (Recurring) per share | -1.21 | -2.85 | -31.69 | -27.76 | -18.62 | -5.77-2089.7% | 0.29 | -1.55 | -0.00 |
| EPS (Basic, Before Extraordinaries) per share | -1.21 | -2.85 | -31.74 | -27.73 | -19.21 | -6.71-813.8% | 0.94 | -1.80 | -0.00 |
| EPS (Diluted) per share | -1.21 | -2.85 | -31.74 | -27.73 | -19.21 | -6.71-813.8% | 0.94 | -1.80 | -0.00 |
| EBITDA | -2.93 | -3.03 | -2.35 | -1.92 | -1.32 | -1.64-16500.0% | 0.01 | -0.53 | -0.50 |
| Non-Operating Income (Expense) | 1.90 | 0.94+840.0% | 0.10+150.0% | 0.04 | -0.06 | -0.02-106.3% | 0.32 | -0.01 | -0.02 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | - | - | - | - | - | - | 8,064.52 | - | - |
| Price To Sales Ratio ratio | 2.80 | 2.80 | 3.47 | 33.85 | 213.10 | 2,959.53 | 817.61 | 2,891.99 | 1,667.14 |
| Gross Margin % | 56.99 | 53.67 | 53.42 | 60.53 | 60.26 | 63.31 | 77.53 | 10.69 | 7.07 |
| Operating Margin % | -295.88 | -213.65 | -194.55 | -150.00 | -82.59 | -182.76 | -4.58 | -62.04 | -32.21 |
| Net Margin % | -114.76 | -149.57 | -186.77 | -146.88 | -90.86 | -248.21 | 10.28 | -78.94 | -33.61 |
| Shares Outstanding million shares | 1.00 | 1.00+1150.0% | 0.080.0% | 0.080.0% | 0.08-72.4% | 0.29-23.7% | 0.380.0% | 0.38 | 376.28 |
| Market Capitalization | 1.36 | 1.36-71.1% | 4.71-90.2% | 48.21-84.1% | 302.56-87.0% | 2,323.68-17.7% | 2,823.39+13.7% | 2,483.42 | 3,123.09 |
Income statement, quarterly
| Metric | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 | 2024Q39/30/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.01-97.9% | 0.27-6.9% | 0.40+11.1% | 0.37+12.1% | 0.47+51.6% | 0.29-9.4% | 0.36-7.7% | 0.33-8.3% |
| Cost of Goods Sold Incl. D&A | 0.04-84.6% | 0.12-20.0% | 0.17-15.0% | 0.13-13.3% | 0.26+100.0% | 0.15+15.4% | 0.20+33.3% | 0.15+7.1% |
| Gross Profit | -0.02-109.5% | 0.16+14.3% | 0.23+43.8% | 0.24+33.3% | 0.21+16.7% | 0.14-26.3% | 0.16-33.3% | 0.18-18.2% |
| Selling, General and Administrative Excl. Other | 0.53-36.9% | 0.84-2.3% | 1.53+51.5% | 0.84+15.1% | 0.84+33.3% | 0.86-5.5% | 1.01-19.2% | 0.73+37.7% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -0.55 | -0.68 | -1.30 | -0.60 | -0.64 | -0.72 | -0.85 | -0.55 |
| Unusual Expense | 0.02 | -0.01 | -0.01 | 0.00 | -0.01-200.0% | 0.00 | -0.00 | 0.00 |
| Net Income Before Taxes | 0.08 | -0.34 | -0.37 | -0.59 | -0.62 | -0.71 | -0.84 | -0.53 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | -0.01-200.0% | -0.00 |
| Consolidated Net Income | 0.08 | -0.34 | -0.38 | -0.60 | -0.62 | -0.71 | -0.83 | -0.52 |
| Net Income From Continuing Operations | 0.09 | -0.33 | -0.38 | -0.59 | -0.62 | -0.70 | -0.81 | -0.51 |
| Net Income | 0.08 | -0.33 | -0.38 | -0.59 | -0.62 | -0.70 | -0.81 | -0.51 |
| EPS (Recurring) per share | 0.09 | -0.34 | -0.38 | -0.58 | -0.62 | -3.63 | -10.15 | -6.55 |
| EPS (Basic, Before Extraordinaries) per share | 0.08 | -0.33 | -0.38 | -0.59 | -0.62 | -3.63 | -10.13 | -6.57 |
| EPS (Diluted) per share | 0.08 | -0.33 | -0.38 | -0.59 | -0.62 | -3.63 | -10.13 | -6.57 |
| EBITDA | -0.51 | -0.63 | -1.24 | -0.55 | -0.58 | -0.67 | -0.78 | -0.50 |
| Non-Operating Income (Expense) | 0.65+6400.0% | 0.32+3100.0% | 0.92+9100.0% | 0.01-50.0% | 0.01-75.0% | 0.01-66.7% | 0.01-50.0% | 0.02 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price To Sales Ratio ratio | 2.80 | 1.74 | 3.50 | 42.60 | 45.66 | 9.52 | 3.56 | 5.59 |
| Gross Margin % | -181.36 | 57.71 | 58.19 | 63.97 | 44.05 | 49.72 | 43.87 | 53.46 |
| Operating Margin % | -4,023.77 | -247.53 | -325.20 | -162.26 | -136.83 | -249.24 | -235.73 | -165.45 |
| Net Margin % | 571.41 | -119.72 | -94.44 | -158.35 | -132.56 | -241.82 | -224.71 | -153.83 |
| Shares Outstanding million shares | 1.000.0% | 1.000.0% | 1.00+1150.0% | 1.00+1150.0% | 1.00+1150.0% | 1.00+1150.0% | 0.080.0% | 0.080.0% |
| Market Capitalization | 1.36-97.9% | 2.63-95.9% | 5.33+13.2% | 63.26+713.1% | 66.01+304.2% | 64.01+151.6% | 4.71-90.2% | 7.78-98.5% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2019FY6/30/2019 | 2018FY6/30/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 23.96+1074.5% | 2.04-57.8% | 4.83+235.4% | 1.44-44.6% | 2.60-26.1% | 3.52+28.5% | 2.74-22.4% | 2.86-19.0% | 3.53 |
| Short Term Receivables | 0.01-83.3% | 0.06-14.3% | 0.07+600.0% | 0.01 | 0.00-100.0% | 0.21-59.6% | 0.52 | 0.51 | 0.00 |
| Inventories | 0.03-83.3% | 0.18+28.6% | 0.14-41.7% | 0.24-64.7% | 0.68+15.3% | 0.59 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.09-82.0% | 0.50+233.3% | 0.15-55.9% | 0.34-46.9% | 0.64-53.3% | 1.37+407.4% | 0.27+3.8% | 0.50+92.3% | 0.26 |
| Total Current Assets | 24.29+773.7% | 2.78-46.4% | 5.19+155.7% | 2.03-48.1% | 3.91-31.2% | 5.68+60.5% | 3.54-6.8% | 3.87+1.8% | 3.80 |
| Net Property, Plant & Equipment | 0.27-38.6% | 0.44-15.4% | 0.52+136.4% | 0.22-51.1% | 0.45-34.8% | 0.69 | 0.00 | 0.00 | 0.00 |
| Total Investments and Advances | 0.020.0% | 0.020.0% | 0.020.0% | 0.02-77.8% | 0.09-84.5% | 0.58-27.5% | 0.80-39.8% | 0.86-35.3% | 1.33 |
| Intangible Assets | 0.010.0% | 0.01-50.0% | 0.020.0% | 0.02 | 0.00-100.0% | 0.01 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | - | 0.00 | 0.00 | - | - | - | - | - | - |
| Other Assets | 0.00 | 0.00 | 0.00-100.0% | 0.50+92.3% | 0.26+4.0% | 0.25 | 0.00 | 0.00 | 0.00 |
| Total Assets | 24.59+659.0% | 3.24-43.6% | 5.74+105.7% | 2.79-40.9% | 4.72-34.5% | 7.21+66.1% | 4.34-15.4% | 4.73-7.8% | 5.13 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.12-29.4% | 0.17+13.3% | 0.15+87.5% | 0.08-50.0% | 0.16+6.7% | 0.15 | 0.00 | 0.00 | 0.00 |
| Accounts Payable | 0.14+7.7% | 0.13+44.4% | 0.09+80.0% | 0.05+400.0% | 0.01 | 0.00 | 0.00 | 0.04 | 0.00 |
| Income Tax Payable | 0.03-62.5% | 0.08+14.3% | 0.07-22.2% | 0.09 | 0.00 | - | 0.00-100.0% | 0.00-100.0% | 0.01 |
| Other Current Liabilities | 1.77+139.2% | 0.74-2.6% | 0.76-24.8% | 1.01-11.4% | 1.14+29.5% | 0.88+1000.0% | 0.08+300.0% | 0.11+450.0% | 0.02 |
| Total Current Liabilities | 2.05+83.0% | 1.12+4.7% | 1.07-13.0% | 1.23-6.1% | 1.31+26.0% | 1.04+1200.0% | 0.08+166.7% | 0.15+400.0% | 0.03 |
| Long Term Debt | 0.11-42.1% | 0.19-34.5% | 0.29 | 0.00-100.0% | 0.08-66.7% | 0.24 | 0.00 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | - | - | - | - | 0.02+100.0% | 0.01 | - | - | - |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 2.17+65.6% | 1.31-3.7% | 1.36+10.6% | 1.23-12.8% | 1.41+9.3% | 1.29+1512.5% | 0.08+166.7% | 0.15+400.0% | 0.03 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 22.46+1063.7% | 1.93-55.8% | 4.37+183.8% | 1.54-53.5% | 3.31-44.1% | 5.92+39.3% | 4.25-16.7% | 4.58-10.2% | 5.10 |
| Total Shareholders Equity | 22.46+1063.7% | 1.93-55.8% | 4.37+183.8% | 1.54-53.5% | 3.31-44.1% | 5.92+39.3% | 4.25-16.7% | 4.58-10.2% | 5.10 |
| Accumulated Minority Interest | -0.03 | -0.00-100.0% | 0.01-50.0% | 0.02 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 22.43+1062.2% | 1.93-55.9% | 4.38+180.8% | 1.56-52.9% | 3.31-44.1% | 5.92+39.3% | 4.25-16.7% | 4.58-10.2% | 5.10 |
| Total Liabilities & Stockholders Equity | 24.59+659.0% | 3.24-43.6% | 5.74+105.7% | 2.79-40.9% | 4.72-34.5% | 7.21+66.1% | 4.34-15.4% | 4.73-7.8% | 5.13 |
| Book Value Per Share per share | 22.45-7.3% | 24.23-57.2% | 56.67+177.3% | 20.44+79.1% | 11.41-27.5% | 15.74+39.3% | 11.30-16.6% | 0.01-99.9% | 13.55 |
| Tangible Book Value Per Share per share | 22.44-6.7% | 24.06-57.4% | 56.44+180.5% | 20.12+76.6% | 11.39-27.5% | 15.72+39.1% | 11.30-16.6% | 0.01-99.9% | 13.55 |
| Full-Time Employees people | 18+12.5% | 16-23.8% | 21-30.0% | 30-16.7% | 36+2.9% | 35+3400.0% | 1 | 1 | - |
| Price to Book Ratio ratio | 0.06 | 2.44 | 113.95 | 135.44 | 701.39 | 476.53 | 584.16 | 621.59 | 621.59 |
| Return on Assets % | -16.38 | -54.99 | -49.25 | -44.89 | -42.30 | 6.15 | -14.33 | -10.54 | - |
| Return on Equity % | -18.69 | -78.40 | -71.12 | -69.49 | -54.65 | 6.97 | -14.50 | -10.74 | - |
| Return on Invested Capital % | -10.10 | -116.33 | -45.10 | -109.40 | -74.32 | 5.75 | -15.94 | -11.35 | -2.56 |
| Quick Ratio ratio | 11.81 | 2.32 | 4.71 | 1.46 | 2.46 | 4.91 | 42.11 | 25.85 | 127.60 |
| Current Ratio ratio | 11.82 | 2.48 | 4.84 | 1.65 | 2.98 | 5.47 | 42.11 | 25.85 | 127.60 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2019FY6/30/2019 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -1.21 | -2.31 | -2.49 | -2.11 | -1.67 | -2.52-820.0% | 0.35 | -0.34 | -0.52 |
| Depreciation | 0.21 | 0.230.0% | 0.23+4.5% | 0.220.0% | 0.220.0% | 0.22+37.5% | 0.16 | - | - |
| Other Funds (Non Cash) | -1.31 | -0.30-372.7% | 0.11+450.0% | 0.02 | -0.16-125.0% | 0.64 | -0.76-1185.7% | 0.07 | 0.47 |
| Funds from Operations | -2.31 | -2.37 | -2.15 | -1.86 | -1.62 | -1.65 | -0.06 | -0.27 | -0.05 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 1.34 | -0.04 | -0.58 | -0.14-124.6% | 0.57-29.6% | 0.81 | -0.74-562.5% | 0.16 | -0.62 |
| Income Taxes Payable | - | -0.00 | 0.00 | -0.01-200.0% | 0.01 | 0.00 | 0.00 | 0.00 | - |
| Cash from Operating Activities | -0.97 | -2.41 | -2.73 | -2.00 | -1.05 | -0.85 | -0.81 | -0.11 | -0.67 |
| Capital Expenditures | 0.00 | -0.00 | -0.05 | -0.05 | -0.03 | -0.00 | -0.00 | 0.00 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00-100.0% | 0.04 | 0.00 | 0.00-100.0% | 1.21 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | -23.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.07 | 0.00 | -0.00 |
| Purchase of Investments | 0.00 | -23.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.07 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.00 | -23.00 | -0.05 | -0.02 | -0.03 | -0.00-100.0% | 1.28 | 0.00 | -0.00 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.00 | 23.00 | 0.00-100.0% | 5.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | -0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 23.00 | 0.00-100.0% | 5.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 23.00 | 0.00-100.0% | 5.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -0.02 | -0.02 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Change in Long Term Debt | -0.02 | -0.02 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -0.02 | -0.02 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.82 | 0.52 | 0.00 | 0.00 | 0.00 | -0.02-108.7% | 0.23 | 0.00 | 0.00 |
| Other Financing Activities Uses | - | - | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 0.80 | 23.50 | -0.01-100.2% | 5.40 | 0.00 | -0.02-108.7% | 0.23 | 0.00 | -0.01 |
| Exchange Rate Effect | 0.01 | 0.02 | -0.00-100.0% | 0.02 | -0.08 | -0.05-162.5% | 0.08 | 0.00 | 0.00 |
| Net Change in Cash | -0.17 | -1.90 | -2.79-182.3% | 3.39 | -1.16 | -0.92-219.5% | 0.77 | -0.11 | -0.67 |
| Free Cash Flow | - | -2.41 | -2.78 | -2.05 | -1.08 | -0.85 | -0.81 | -0.11 | -0.67 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | -0.00 | -0.01-200.0% | 0.01-94.4% | 0.18 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 | 2024Q39/30/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 24.58+5.9% | 24.34+3.2% | 23.96+1074.5% | 23.13+750.4% | 23.22+634.8% | 23.58+558.7% | 2.04-57.8% | 2.72+777.4% |
| Short Term Receivables | 0.00-100.0% | 0.01-80.0% | 0.01-83.3% | 0.01-80.0% | 0.03-40.0% | 0.05+25.0% | 0.06-14.3% | 0.05+150.0% |
| Inventories | 0.24+20.0% | 0.23+35.3% | 0.23+27.8% | 0.170.0% | 0.20+33.3% | 0.17+13.3% | 0.18+28.6% | 0.170.0% |
| Other Current Assets | 0.02-97.8% | 0.07-92.9% | 0.09-82.0% | 0.76+61.7% | 0.90+91.5% | 0.98+96.0% | 0.50+233.3% | 0.47+2250.0% |
| Total Current Assets | 24.83+2.0% | 24.65-0.5% | 24.29+773.7% | 24.07+607.9% | 24.35+535.8% | 24.78+480.3% | 2.78-46.4% | 3.40+541.5% |
| Net Property, Plant & Equipment | 0.10-70.6% | 0.21-44.7% | 0.27-38.6% | 0.29-46.3% | 0.34-17.1% | 0.38-17.4% | 0.44-15.4% | 0.54+17.4% |
| Total Investments and Advances | 0.020.0% | 0.03+200.0% | 0.020.0% | 0.02+100.0% | 0.02+100.0% | 0.01-50.0% | 0.020.0% | 0.01-50.0% |
| Intangible Assets | 0.00-100.0% | 0.010.0% | 0.010.0% | 0.01-50.0% | 0.010.0% | 0.01-50.0% | 0.01-50.0% | 0.020.0% |
| Deferred Tax Assets | - | - | - | - | - | - | 0.00 | 0.00-100.0% |
| Other Assets | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% |
| Total Assets | 25.03+1.3% | 24.91-1.1% | 24.59+659.0% | 24.39+515.9% | 24.72+478.9% | 25.18+427.9% | 3.24-43.6% | 3.96+140.0% |
| Short Term Debt Incl. Current Port. of LT Debt | 0.03-82.4% | 0.08-52.9% | 0.12-29.4% | 0.14-26.3% | 0.17+13.3% | 0.17+13.3% | 0.17+13.3% | 0.19+46.2% |
| Accounts Payable | 0.14+16.7% | 0.15+50.0% | 0.14+7.7% | 0.12+9.1% | 0.12+140.0% | 0.10+66.7% | 0.13+44.4% | 0.11+57.1% |
| Income Tax Payable | 0.03-62.5% | 0.03-62.5% | 0.03-62.5% | 0.07-22.2% | 0.08-11.1% | 0.080.0% | 0.08+14.3% | 0.09+28.6% |
| Other Current Liabilities | 2.74+230.1% | 2.48+281.5% | 1.77+139.2% | 1.15+105.4% | 0.83+59.6% | 0.65+16.1% | 0.74-2.6% | 0.56-20.0% |
| Total Current Liabilities | 2.94+145.0% | 2.74+174.0% | 2.05+83.0% | 1.49+56.8% | 1.20+48.1% | 1.00+19.0% | 1.12+4.7% | 0.95-2.1% |
| Long Term Debt | 0.03-75.0% | 0.10-33.3% | 0.11-42.1% | 0.10-60.0% | 0.12-42.9% | 0.15-40.0% | 0.19-34.5% | 0.250.0% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 2.97+126.7% | 2.84+147.0% | 2.17+65.6% | 1.59+32.5% | 1.31+28.4% | 1.15+5.5% | 1.31-3.7% | 1.20-1.6% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 22.05-5.9% | 22.12-8.0% | 22.46+1063.7% | 22.83+730.2% | 23.43+627.6% | 24.05+557.1% | 1.93-55.8% | 2.75+554.8% |
| Total Shareholders Equity | 22.05-5.9% | 22.12-8.0% | 22.46+1063.7% | 22.83+730.2% | 23.43+627.6% | 24.05+557.1% | 1.93-55.8% | 2.75+554.8% |
| Accumulated Minority Interest | 0.00 | -0.05 | -0.03 | -0.03-250.0% | -0.02-166.7% | -0.02-200.0% | -0.00-100.0% | 0.02+100.0% |
| Total Equity | 22.05-5.8% | 22.07-8.2% | 22.43+1062.2% | 22.80+726.1% | 23.41+620.3% | 24.03+553.0% | 1.93-55.9% | 2.76+541.9% |
| Total Liabilities & Stockholders Equity | 25.03+1.3% | 24.91-1.1% | 24.59+659.0% | 24.39+515.9% | 24.72+478.9% | 25.18+427.9% | 3.24-43.6% | 3.96+140.0% |
| Book Value Per Share per share | 22.04-5.9% | 22.10-8.1% | 22.45-7.3% | 22.83-33.7% | 23.43-44.0% | 24.05-49.4% | 24.23-57.2% | 34.44+513.9% |
| Tangible Book Value Per Share per share | 22.04-5.9% | 22.10-8.1% | 22.44-6.7% | 22.82-33.4% | 23.42-43.8% | 24.04-49.2% | 24.06-57.4% | 34.25+539.0% |
| Full-Time Employees people | - | - | 18+12.5% | - | - | - | 16-23.8% | - |
| Price to Book Ratio ratio | 0.06 | 0.12 | 0.24 | 2.77 | 2.82 | 2.66 | 2.44 | 2.83 |
| Return on Assets % | -4.84 | -7.62 | -16.38 | -19.13 | -18.17 | -16.42 | -54.99 | -93.91 |
| Return on Equity % | -5.30 | -8.27 | -18.69 | -21.20 | -19.77 | -17.75 | -78.40 | -166.30 |
| Return on Invested Capital % | 0.35 | -1.47 | -1.67 | -2.56 | -2.62 | -2.89 | -38.07 | -16.98 |
| Quick Ratio ratio | 8.37 | 8.93 | 11.71 | 16.09 | 20.18 | 24.50 | 2.32 | 3.41 |
| Current Ratio ratio | 8.45 | 9.01 | 11.82 | 16.21 | 20.35 | 24.67 | 2.48 | 3.59 |
Cash flow, quarterly
| Metric | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 | 2024Q39/30/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | 0.10 | -0.34 | -0.38 | -0.60 | -0.62 | -0.71 | -0.83 | -0.52 |
| Depreciation | 0.03-25.0% | 0.050.0% | 0.090.0% | 0.04-20.0% | 0.04-20.0% | 0.050.0% | 0.09+80.0% | 0.05-16.7% |
| Other Funds (Non Cash) | -0.68 | -0.31-1133.3% | -0.34-666.7% | 0.020.0% | 0.00-100.0% | 0.03 | 0.06-57.1% | 0.02 |
| Funds from Operations | -0.54 | -0.60 | -0.63 | -0.53 | -0.58 | -0.64 | -0.68 | -0.46 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 0.43+437.5% | 0.20 | 0.42+950.0% | 0.28+833.3% | 0.08 | -0.82 | 0.04 | 0.03+200.0% |
| Income Taxes Payable | - | - | 0.00 | -0.00 | 0.00-100.0% | 0.00-100.0% | -0.01 | -0.00 |
| Cash from Operating Activities | -0.11 | -0.39 | -0.21 | -0.26 | -0.49 | -1.45 | -0.65 | -0.42 |
| Capital Expenditures | 0.00 | 0.00 | -0.00 | -7E-06 | -0.00 | -0.00 | -0.00 | -0.05 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 1E-06-100.0% | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -23.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -23.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 0.00 | 0.00 | -0.00 | -7E-06 | -0.00 | -23.00 | -0.00 | -0.05 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 23.00 | 0.00-100.0% | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 23.00 | 0.00-100.0% | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 23.00 | 0.00-100.0% | 0.00 |
| Issuance or Reduction of Debt, Net | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 |
| Change in Long Term Debt | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 |
| Net Financing Active Other Cash Flow | -0.08-161.5% | 0.50 | 0.21 | 0.19 | 0.13 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | - | - | - | - | - | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | -0.08-166.7% | 0.50-97.8% | 0.20 | 0.18 | 0.12 | 22.99 | -0.01-100.2% | -0.00 |
| Exchange Rate Effect | 0.02+100.0% | -0.02 | 0.01 | -0.01-133.3% | 0.01 | -0.00 | -0.03-200.0% | 0.03 |
| Net Change in Cash | -0.17 | 0.08 | 0.01 | -0.08 | -0.36 | -1.46 | -0.68-115.0% | -0.44 |
| Free Cash Flow | - | -0.39 | -0.21 | -0.26 | -0.49 | -1.45 | -0.65 | -0.47 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Energized Mineral Concentrate | 0.04 | 0.06 | +35.7% | 3.9% |
| Green Energy | 0.04 | 0.14 | +226.7% | 9.2% |
| Health and Wellness Services | 0.21 | 0.17 | -18.4% | 11.1% |
| Ionized Cal Mag | 0.00 | - | - | - |
| LIVO 5 | 0.08 | 0.01 | -89.6% | 0.5% |
| Mix Soy Protein Isolate Powder With Black Sesame | 0.01 | 0.00 | -66.5% | 0.2% |
| Product Health Therapies | 0.91 | 0.91 | -0.1% | 59.8% |
| Skin Care and Health Care Products | 0.02 | 0.23 | +948.9% | 15.2% |
| Soy Protein Isolate Powder | 0.01 | 0.00 | -80.1% | 0.1% |
| Total | 1.32 | 1.52 | +15.2% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Malaysia | 1.32 | 1.52 | +15.2% | 100.0% |
| Total | 1.32 | 1.52 | +15.2% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Green Energy | 0.04 | 0.14 | +226.7% | 9.2% |
| Skin Care Health And Wellness | 1.28 | 1.38 | +8.2% | 90.8% |
| Total | 1.32 | 1.52 | +15.2% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 0.41% | 0.0M | 0.5M | 132.92K |
| 2026-10-15 | 1.48% | 0.0M | 0.5M | 801.19K |
| 2026-09-30 | 2.08% | 0.0M | 0.5M | 831.68K |
| 2026-09-15 | 4.90% | 0.0M | 0.5M | 2.07M |
| 2026-08-31 | 4.46% | 0.0M | 0.5M | 2.17M |
| 2026-08-14 | 5.02% | 0.0M | 0.5M | 4.07M |
| 2026-07-31 | 6.19% | 0.0M | 0.5M | 3.97M |
| 2026-07-15 | 3.28% | 0.0M | 0.5M | 3.34M |
| 2026-06-30 | 3.38% | 0.0M | 0.5M | 3.27M |
| 2026-06-15 | 4.00% | 0.0M | 0.5M | 2.10M |
| 2026-05-29 | 66.84% | 0.3M | 0.5M | 3.79M |
| 2026-05-15 | 1.11% | 0.0M | 0.5M | 1.93M |
| 2026-04-30 | 2.06% | 0.0M | 0.5M | 1.99M |
| 2026-04-15 | - | 0.0M | - | 2.05M |
| 2026-03-31 | - | 0.0M | - | 2.23M |
| 2026-03-13 | - | 0.5M | - | 2.34M |
| 2026-02-27 | 40.96% | 0.0M | 0.1M | 812.52K |
| 2026-02-13 | 21.13% | 0.0M | 0.1M | 804.33K |
| 2026-01-30 | 19.67% | 0.0M | 0.1M | 762.86K |
| 2026-01-15 | 26.54% | 0.0M | 0.1M | 718.80K |
Option chain
expiry 2026-11-13| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-06 | SCHEDULE 13G/A | SEC | ||
| 2026-08-14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-07-20 | S-1/A | SEC | ||
| 2026-07-15 | SCHEDULE 13G | SEC | ||
| 2026-06-08 | S-1 | General form of registration statement for all companies including face-amount certificate companies | SEC | |
| 2026-05-15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-03-31 | SEC |
| 2026-04-13 | 10-K | Annual report pursuant to Section 13 or 15(d) | 2025-12-31 | SEC |
| 2026-03-31 | NT 10-K | 2025-12-31 | SEC | |
| 2026-03-12 | 8-K | Current report | 2026-03-12 | SEC |
| 2026-03-10 | 8-K | Current report | 2026-03-10 | SEC |
| 2026-02-06 | S-3 | Registration statement for specified transactions by certain issuers including face-amount certificate companies | SEC | |
| 2026-02-06 | 8-K | Current report | 2026-02-06 | SEC |
| 2026-02-05 | 8-K | Current report | 2026-02-05 | SEC |
| 2026-02-02 | 8-K | Current report | 2026-01-30 | SEC |
| 2026-01-29 | 8-K | Current report | 2026-01-27 | SEC |
| 2026-01-28 | DEFR14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | SEC | |
| 2026-01-09 | DEF 14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | 2026-01-09 | SEC |
| 2025-12-23 | PRER14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | SEC | |
| 2025-12-12 | 8-K | Current report | 2025-12-12 | SEC |
| 2025-12-10 | PRE 14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | 2025-12-10 | SEC |
| 2025-11-28 | 8-K | Current report | 2025-11-24 | SEC |
| 2025-11-13 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2025-09-30 | SEC |
| 2025-08-13 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2025-06-30 | SEC |
| 2025-07-08 | 8-K | Current report | 2025-07-08 | SEC |
| 2025-05-15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2025-03-31 | SEC |
| 2025-04-22 | 424B3 | SEC | ||
| 2025-04-21 | EFFECT | Effectiveness filing by commission order | SEC | |
| 2025-04-17 | CORRESP | SEC | ||
| 2025-04-16 | S-1/A | SEC | ||
| 2025-04-15 | UPLOAD | Upload Submission | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| HRT FINANCIAL LP | 5.88% |
| JANE STREET GROUP, LLC | 3.82% |
| UBS Group AG | 0.32% |
| Caitong International Asset Management Co., Ltd | 0.00% |
| JPMORGAN CHASE & CO | 0.00% |
Funds
| Fund | % owned |
|---|---|
| Fidelity Nasdaq Composite Index Fund | 0.00% |
OakChart. ATPC. Cached 15 minutes. Terms
Some panels did not load: ratings, insider.